Recursion, Roche, and its Genentech subsidiary have unveiled a whole-genome map of specialized microglial immune cells that they plan to use toward revealing significant new targets in ...

Virtual screening methods fall broadly into two categories: ligand- and structure-based. Ligand-based virtual screening doesn’t require a target protein structure, Instead, it leverages known active ...

Stream Finance pauses operations after a $93M loss and XUSD stablecoin drops 76%, highlighting transparency & risk issues in the DeFi sector.

Discover how Zero Knowledge Proof (ZKP) unlocks infinite scalability through recursive proofs. Join the whitelist soon to pre ...

If language is what makes us human, what does it mean now that large language models have gained “metalinguistic” abilities?

We recently published 10 Stocks Stealing Today’s Spotlight; 5 on All-Time Highs. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best performers on Wednesday. Recursion Pharmaceuticals ...

In this week’s edition of InnovationRx, we look Nvidia’s collaborations in life sciences and drug development, Cobot’s ...

AI in biotechnology is rapidly transforming genetic engineering, personalized medicine, and drug discovery by enabling faster ...

BCC Research analyzes how AI-driven discovery tools, predictive analytics, and scalable cloud platforms are transforming biotechnology's future.”Boston, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Artificial ...

For years, privacy-focused blockchains were seen as side projects with limited reach. That’s about to change with Zero Knowledge Proof (ZKP). Built as a privacy ...